Press Releases :: CohBar, Inc. (CWBR)

CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunotherapy

The companies hosted a joint webcast on May 23, 2023, to discuss the transaction.

Morphogenesis Website

Access Webcast Replay

May 19, 2022 4:02pm EDT

CohBar to Present at the H.C. Wainwright Global Investment Conference

May 16, 2022 4:01pm EDT

CohBar Reports First Quarter 2022 Financial Results and Highlights Recent Corporate Progress

May 12, 2022 9:00am EDT

CohBar Announces Extension of Nasdaq Compliance Period and Summarizes 2022 Annual Meeting Proposal

May 02, 2022 9:00am EDT

CohBar to Announce 2022 First Quarter Financial Results and Provide Business Update on May 16, 2022

Mar 29, 2022 4:01pm EDT

CohBar Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update

Mar 15, 2022 9:00am EDT

CohBar to Announce 2021 Fourth Quarter and Full-Year Financial Results and Provide Business Update on March 29, 2022

Jan 03, 2022 9:00am EST

CohBar to Present at H.C. Wainwright BIOCONNECT Conference

Dec 17, 2021 9:00am EST

CohBar Announces Changes to its Board of Directors and R&D Leadership

Nov 29, 2021 9:00am EST

CohBar’s CEO to Participate in Upcoming BIO Webinar

Nov 15, 2021 4:02pm EST

CohBar Reports Third Quarter 2021 Financial Results and Provides Business Update